Topics:
imatinib mesylate
In the letter by McCann entitled “Molecular response to imatinib mesylate following relapse after allogeneic SCT for CML,” which appeared in the February 1, 2003, issue of Blood(Volume 101:1200), 3 coauthors were omitted: Kathy Gately, Eibhlin Conneally, and Mark Lawler.
Copyright © 2003 The American Society of Hematology
2003
